Completed NA INTERVENTIONAL 2-arm NCT00986986

Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels

Prospective Randomized Pilot Study of the Effect of Niaspan on Endothelial Function in HIV-infected Subjects With Low HDL Cholesterol Levels

Sponsor: United States Department of Defense

Conditions Dyslipidemia Endothelial Dysfunction HIV Infections

Interventions extended release niacin

Updated 10 times since 2017 Last updated: Nov 19, 2012 Started: Nov 30, 2007 Primary completion: Apr 30, 2010 Completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Dyslipidemia and Endothelial Dysfunction, this trial is completed. The trial is conducted by United States Department of Defense and has accumulated 10 data snapshots since 2007. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2021 [monthly]

Completed NA
Nov 2020 — Jan 2021 [monthly]

Completed NA

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed NA
May 2018 — Jun 2018 [monthly]

Completed NA
Aug 2017 — May 2018 [monthly]

Completed NA
Feb 2017 — Aug 2017 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

United States Department of Defense
University of Hawaii

Data source: University of Hawaii

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Honolulu, United States